Authors

Content director at The Vanguard Network, an advisory organization that connects industry leaders through in-person forums and virtual exchanges. His work has appeared in publications such as The Wall Street Journal and Financial Times.

Donna R. Cryer, J.D.

Donna R. Cryer, J.D., is a co-founder of CryerHealth, a boutique consulting firm, and a pioneer in the science of patient engagement. CryerHealth has advised dozens of corporate, governmental and charitable organizations. Driven by her own journey through pediatric IBD and liver transplantation, Donna is also the Founder and CEO Emerita of Global Liver Institute (GLI), which has helped shape and define the field of liver health across five continents. She has served on more than 30 boards and committees for universities, health systems, and government agencies, and has more published numerous peer-reviewed papers.

Michelle Longmire, MD

Dr. Longmire is a Stanford-trained physician scientist who is passionate about improving human health through advancements in clinical research. She is driven to reduce the cost and time required to develop new therapies for disease. Dr. Longmire founded Medable, a platform technology company committed to accelerating drug development, by improving evidence generation in clinical trials.

Lloyd Cobb

Senior Vice President, EMEA + APAC at Planet Pharma.

The president and head of U.S. commercial at Astellas. Prior to Astellas, Petroutsas served as senior vice president, U.S. Specialty and Oncology Business, at GSK. There he successfully launched the US Oncology division and focused on commercializing medicines to help many patients with complex diseases in immunology, hepatology, respiratory and renal areas. Before that, he held senior positions at Pfizer and Novartis Oncology.

Nacho Quinones, Ph.D.

Nacho Quinones, Ph.D., is a Senior Principal at IQVIA specializing in medical affairs strategy. With more than 15 years across life sciences and management consulting, he designs and executes transformative medical affairs programs, builds tech-enabled capabilities and helps organizations disseminate impactful medical evidence, drawing on deep expertise in operating model design and change management. He holds a Ph.D. in biochemistry from King's College London and a BSc in biochemistry from Imperial College London, alongside professional qualifications in business accounting.

Is vice president, offering development within IQVIA’S global commerce offering business responsible for global launch excellence. Over the past 25 years, she has worked with some of the world’s most successful brands across both the pharma and CPG industries in Europe, the Americas, and Southeast Asia.